Journal article
Treatment selection in oropharyngeal cancer: a surveillance, epidemiology, and end results (SEER) patterns of care analysis
Cancer causes & control, Vol.28(10), pp.1085-1093
10/2017
DOI: 10.1007/s10552-017-0938-3
PMCID: PMC5771802
PMID: 28815336
Abstract
Treatment for oropharyngeal cancer (OPC) has changed over the past two decades under multiple influences. We provide a population-based description of the application of radiotherapy, surgery, and chemotherapy to OPC in 1997, 2004, and 2009.
The National Cancer Institute's Patterns of Care study for OPC included multiple variables not available in the public-use dataset. We identified factors correlating with selection of primary surgery versus radiotherapy with or without chemotherapy (RTC) and analyzed predictors of all-cause mortality. We estimated the frequency of human papillomavirus (HPV) testing.
RTC was more common in 2009 than in 1997, and was more commonly applied to Stage IV cases. However, RTC was not an independent risk factor for mortality compared with surgery. HPV status was known in 14% of patients in 2009.
RTC is the most common treatment for OPC, but it may not provide the best outcomes. HPV testing was uncommon in 2009.
Details
- Title: Subtitle
- Treatment selection in oropharyngeal cancer: a surveillance, epidemiology, and end results (SEER) patterns of care analysis
- Creators
- Nitin A Pagedar - Department of Otolaryngology - Head and Neck Surgery, University of Iowa, 200 Hawkins Drive, 21200 PFP, Iowa City, IA, 52242, USA. nitin-pagedar@uiowa.eduCatherine Chioreso - Department of Epidemiology, University of Iowa, Iowa City, IA, USAJennifer A Schlichting - Department of Epidemiology, University of Iowa, Iowa City, IA, USACharles F Lynch - State Health Registry of Iowa, Iowa City, IA, USAMary E Charlton - Department of Epidemiology, University of Iowa, Iowa City, IA, USA
- Resource Type
- Journal article
- Publication Details
- Cancer causes & control, Vol.28(10), pp.1085-1093
- DOI
- 10.1007/s10552-017-0938-3
- PMID
- 28815336
- PMCID
- PMC5771802
- NLM abbreviation
- Cancer Causes Control
- ISSN
- 0957-5243
- eISSN
- 1573-7225
- Publisher
- Netherlands
- Grant note
- HHSN26100006 / National Cancer Institute P30CA086862 / National Cancer Institute (US) HHSN261201300020I / National Cancer Institute HHSN261201300020I / NCI NIH HHS P30 CA086862 / NCI NIH HHS
- Language
- English
- Date published
- 10/2017
- Academic Unit
- Health Management and Policy; Epidemiology; Otolaryngology
- Record Identifier
- 9983996064602771
Metrics
25 Record Views